Skip to main content

Published locations for Survival benefit with nivolumab extends to 5 years in NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Survival benefit with nivolumab extends to 5 years in NSCLC

User login

  • Reset your password
  • /content/survival-benefit-nivolumab-extends-5-years-nsclc
  • /fedprac/article/239151/lung-cancer/survival-benefit-nivolumab-extends-5-years-nsclc
  • /oncologypractice/article/239151/lung-cancer/survival-benefit-nivolumab-extends-5-years-nsclc
  • /fedprac/avaho/article/239151/lung-cancer/survival-benefit-nivolumab-extends-5-years-nsclc
  • /hematology-oncology/article/239151/lung-cancer/survival-benefit-nivolumab-extends-5-years-nsclc
  • /chestphysician/article/239151/lung-cancer/survival-benefit-nivolumab-extends-5-years-nsclc